A*Star's enterprise office inks US$90m deal for healthcare deep-tech startups

Nasdaq-listed Aptorum Group and A*ccelerate seeks to develop up to 20 deeptech ventures up over the next five years.

Nasdaq-listed Aptorum Group, Aeneas Capital, and A*ccelerate Technologies, the enterprise office of A*STAR, have signed a US$90m agreement to co-create local deep tech startups in the healthcare and life sciences sector.

Through this agreement, Aptorum Group and A*ccelerate are looking at creating up to 20 deep tech ventures in Singapore over the next five years. These enterprises will use the technologies co-developed by A*STAR research institutes and Aptorum Group.

One of the areas both parties are looking into is the translation of A*STAR’s capabilities in medical image analytics and augmented reality, into real-time 2D and 3D magnetic resonance imaging (MRI) surgical imaging solutions for applications in the field of surgical robotics.

Aptorum Group and Aeneas Capital will also be launching a healthcare and life science strategic investment fund of up to US$200m. Aptorum Group and Aeneas Capital will also make acquisitions in identified technologies and businesses globally.

Also Read

Synpaxe, tech giants foster GenAI in healthcare

MOH suspends Peach Gardens after gastroenteritis outbreak

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit